Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Director departure
CC transcript
Quarterly results
|
|
Aegerion Pharmaceuticals, Inc. (AEGR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/01/2016 |
SC 13D/A
| Broadfin Capital, LLC reports a 0% stake in Aegerion Pharmaceuticals, Inc. |
| 11/30/2016 |
SC 13D/A
| Sarissa Capital Management LP reports a 0% stake in Aegerion Pharmaceuticals, Inc. |
| 06/16/2016 |
SC 13D/A
| Sarissa Capital Management LP reports a 9% stake in Aegerion Pharmaceuticals, Inc. |
| 03/22/2016 |
SC 13D/A
| Sarissa Capital Management LP has filed a Schedule 13D for Aegerion Pharmaceuticals, Inc. |
| 02/19/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 01/23/2013 |
SC 13D/A
| Aegerion Pharmaceuticals, Inc. reports a 4.1% stake in AEGERION PHARMACEUTICALS, INC. |
| 12/19/2012 |
SC 13D/A
| ALTA BIOPHARMA PARTNERS III LP reports a 5.8% stake in Aegerion Pharmaceuticals, Inc. |
| 11/05/2012 |
SC 13D/A
| Aegerion Pharmaceuticals, Inc. reports a 8.7% stake in Aegerion Pharmaceuticals, Inc. |
| 10/22/2012 |
SC 13D/A
| ALTA BIOPHARMA PARTNERS III LP reports a 8.6% stake in Aegerion Pharmaceuticals, Inc. |
| 02/01/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 07/07/2011 |
SC 13D/A
| Index Venture Associates III Ltd reports a 10.4% stake in AEGERION PHARMACEUTICALS, INC. |
|
|